Linkedin Facebook Twitter
Sign up

International Medical Approval

Latest International Medical Approval
Guardant Health Receives Regulatory Approval from Singapore’s Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers
International Medical Approval
/ June 4, 2023, 04:12 UTC
Nippon Express Italia Obtains IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport
International Medical Approval
/ June 4, 2023, 04:12 UTC
CARsgen’s CLDN18.2 mAb AB011 Achieves IND Clearance from the NMPA for the First-line Combination Treatment of Gastric Cancer
International Medical Approval
/ June 2, 2023, 20:12 UTC
CARsgen’s CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer
International Medical Approval
/ May 20, 2023, 20:12 UTC
The World’s Second Approved Biosimilars of Denosumab (MAILISHU)
International Medical Approval
/ May 3, 2023, 13:12 UTC
ImmVira’s oncolytic product MVR-C5252 targeting malignant glioma obtained NMPA’s approval for Clinical Trial in China
International Medical Approval
/ April 29, 2023, 07:12 UTC
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab
International Medical Approval
/ April 27, 2023, 15:12 UTC
CARsgen Announced 2022 Annual Results and Business Updates
International Medical Approval
/ April 21, 2023, 20:12 UTC
Lunit Meets MDR CE Requirements for 3D Breast Tomosynthesis AI Solution
International Medical Approval
/ April 19, 2023, 20:12 UTC
Mallinckrodt Announces Reimbursement Approval in Japan for the CELLEX® Extracorporeal Photopheresis (ECP) System for the Treatment of Chronic Graft Versus Host Disease (cGvHD)
International Medical Approval
/ April 3, 2023, 13:12 UTC
GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting
International Medical Approval
/ March 30, 2023, 08:12 UTC
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND
International Medical Approval
/ March 28, 2023, 15:12 UTC
Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO® (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One Prior Therapy
International Medical Approval
/ March 22, 2023, 20:12 UTC
NMPA accepted the registration applications for Uro-G and Uro-3500
International Medical Approval
/ March 20, 2023, 21:12 UTC
GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS
International Medical Approval
/ March 1, 2023, 19:12 UTC
Help Therapeutics Announces IND Approval of First Universal iPSC-derived Cardiomyocyte Therapy for End-stage Heart Failure in China
International Medical Approval
/ February 28, 2023, 23:12 UTC
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
International Medical Approval
/ February 17, 2023, 20:12 UTC
Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations
International Medical Approval
/ February 9, 2023, 16:12 UTC

Subscribe today and save your spot

News & Trends

Buying Guide

Topics

Generated by Feedzy

Are you in?

Subscribe to receive exclusive content and notifications to your inbox